The Time Has Come: Identification and Treatment of Opioid Use Disorder

The Time Has Come: Identification and Treatment of Opioid Use Disorder

This activity is supported by an educational grant from Indivior Inc.


Author(s)/Faculty: Brent Boyett, DMD, DO, FAAFP, ABAM; Stephen M. Taylor , MD, MPH, FASAM ; Steven L. Wright, MD, FAAFP, FASAM
Source: Healio Education Lab - Psychiatry
Type: MonographArticles/Items: 6
Release Date: 12/20/2017Expiration Date: 12/19/2018
Credit Type: CMENumber of Credits: 1.5
Cost: FreeProvider: Vindico Medical Education
According to the 2015 National Survey on Drug Use and Health, 2.4 million people suffered from opioid use disorder (OUD) in the United States. In Canada, as many as 200,000 individuals were estimated to be addicted to prescription painkillers (2012), whereas a potential 1.3 million opioid users at high-risk for addiction were noted in Europe (2014). In 2014, Australia ranked as the third-highest country worldwide for prescription painkiller misuse per year and China had an estimated 7.3 million people dependent on opioids. In this CME activity, an overview of the OUD epidemic will be presented, followed by an examination of the efficacy of current and emerging medications for medication-assisted therapy (MAT) for OUD. To recognize patients at risk of OUD, physicians will be educated on the differentiation of addiction, pseudoaddiction, and physical dependence. A discussion of adequate training and MAT certification for OUD treatment, as well as presentation of clinical practice guidelines, will enhance the education needed in this important treatment area. The interactive case-based format is intended to help clinicians integrate scientific advances into real-world practice settings.

CME Information

page 1 of 9